413
Views
10
CrossRef citations to date
0
Altmetric
Special issue on Inflammation in Aging and Age-related Diseases

Reduction of glucose intolerance with high fat feeding is associated with anti-inflammatory effects of thioredoxin 1 overexpression in mice

, , , , &
Article: 17101 | Received 06 Jan 2012, Accepted 10 Apr 2012, Published online: 17 May 2012

References

  • DeFronzo RA. Glucose intolerance and aging. 1981; 4: 493-501. 10.3402/pba.v2i0.17101.
  • Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. 2010; 59: 89-97. 10.3402/pba.v2i0.17101.
  • Jackson RA, Hawa MI, Roshania RD, Sim BM, DiSilvio L, Jaspan JB Influence of aging on hepatic and peripheral glucose metabolism in humans. 1988; 37: 119-29. 10.3402/pba.v2i0.17101.
  • Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. 2002; 51: 2951-8. 10.3402/pba.v2i0.17101.
  • Gambert SR, Pinkstaff S. Emerging epidemic: diabetes in older adults: demography, economic impact, and pathophysiology. 2006; 19: 221-8. 10.3402/pba.v2i0.17101.
  • Bruunsgaard H. The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. 2006; 53: 285-309.
  • Kim HJ, Jung KJ, Yu BP, Cho CG, Choi JS, Chung HY Modulation of redox-sensitive transcription factors by calorie restriction during aging. 2002; 123: 1589-95. 10.3402/pba.v2i0.17101.
  • Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY et al. Molecular inflammation: underpinnings of aging and age-related diseases. 2009; 8: 18-30. 10.3402/pba.v2i0.17101.
  • Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. 2006; 116: 1793-801. 10.3402/pba.v2i0.17101.
  • Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. 1996; 271: 665-70. 10.3402/pba.v2i0.17101.
  • Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNFalpha function. 1997; 389: 610-4. 10.3402/pba.v2i0.17101.
  • Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. 2003; 278: 45777-84. 10.3402/pba.v2i0.17101.
  • Nguyen MTA, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI et al. JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. 2005; 280: 35361-71. 10.3402/pba.v2i0.17101.
  • Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K et al. A central role for JNK in obesity and insulin resistance. 2002; 420: 333-6. 10.3402/pba.v2i0.17101.
  • Powis G, Montfort WR. Properties and biological activities of thioredoxins. 2001; 30: 421-55. 10.3402/pba.v2i0.17101.
  • Bertini R, Zack Howard OM, Dong H-F, Oppenheim JJ, Bizzarri C, Sergi R et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. 1999; 189: 1783-9. 10.3402/pba.v2i0.17101.
  • Sato A, Hoshino Y, Hara T, Muro S, Nakamura H, Mishima M et al. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice. 2008; 325: 380-8. 10.3402/pba.v2i0.17101.
  • Kaimul Ahsan M, Nakamura H, Tanito M, Yamada K, Utsumi H, Yodoi J Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt. 2005; 39: 1549-59. 10.3402/pba.v2i0.17101.
  • Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y et al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. 2001; 98: 15143-8. 10.3402/pba.v2i0.17101.
  • Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N et al. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. 2006; 131: 1110-21. 10.3402/pba.v2i0.17101.
  • Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan MK et al. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. 2004; 110: 1276-83. 10.3402/pba.v2i0.17101.
  • Tobiume K, Saitoh M, Ichijo H. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. 2002; 191: 95-104. 10.3402/pba.v2i0.17101.
  • Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. 2002; 4: 693-6. 10.3402/pba.v2i0.17101.
  • Perez VI, Cortez LA, Lew CM, Rodriguez M, Webb CR, Van Remmen H, et al. Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice. . 2011; 66: 1286–99.10.3402/pba.v2i0.17101.
  • Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. 2003; 112: 1821-30.
  • Coon PJ, Rogus EM, Drinkwater D, Muller DC, Goldberg AP. Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. 1992; 75: 1125-32. 10.3402/pba.v2i0.17101.
  • Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E et al. Metabolic effects of visceral fat accumulation in type 2 diabetes. 2002; 87: 5098-103. 10.3402/pba.v2i0.17101.
  • Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AJ Jr Obesity is associated with macrophage accumulation in adipose tissue. 2003; 112: 1796-808.
  • Miyamoto S, Kawano H, Hokamaki J, Soejima H, Kojima S, Kudoh T et al. Increased plasma levels of thioredoxin in patients with glucose intolerance. 2005; 44: 1127-32. 10.3402/pba.v2i0.17101.
  • Kakisaka Y, Nakashima T, Sumida Y, Yoh T, Nakamura H, Yodoi J et al. Elevation of serum thioredoxin levels in patients with type 2 diabetes. 2002; 34: 160-4. 10.3402/pba.v2i0.17101.
  • Ceriello A. New insights on oxidative stress and diabetic complications may lead to a ‘Causal’ antioxidant therapy. 2003; 26: 1589-96. 10.3402/pba.v2i0.17101.
  • Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. 2004; 279: 30369-74. 10.3402/pba.v2i0.17101.
  • Turturro F, Friday E, Welbourne T. Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231. 2007; 7: 9610.3402/pba.v2i0.17101.
  • Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. 2004; 114: 1752-61.
  • Grimsrud PA, Picklo MJ, Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance. 2007; 6: 624-37. 10.3402/pba.v2i0.17101.
  • Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Mahgzal GJ et al. Insulin resistance is a cellular antioxidant defense mechanism. 2009; 106: 17787-92. 10.3402/pba.v2i0.17101.
  • Chen L, Na R, Gu M, Salmon AB, Liu Y, Liang H et al. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. 2008; 7: 866-78. 10.3402/pba.v2i0.17101.
  • Lee HY, Choi CS, Birkenfeld AL, Alves TC, Jornayvaz FR, Jurczak MJ et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. 2010; 12: 668-74. 10.3402/pba.v2i0.17101.
  • Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. 2009; 119: 573-81. 10.3402/pba.v2i0.17101.
  • Ohashi S, Nishio A, Nakamura H, Kido M, Ueno S, Uza N et al. Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. 2006; 290: G772-81. 10.3402/pba.v2i0.17101.
  • Takeuchi J, Hirota K, Itoh T, Shinkura R, Kitada K, Yodoi J et al. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-κB activation at a level upstream of NF-κB-inducing kinase. 2000; 2: 83-92. 10.3402/pba.v2i0.17101.
  • Salmon AB, Richardson A, Perez VI. Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging?. 2010; 48: 642-55. 10.3402/pba.v2i0.17101.
  • Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J et al. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. 1998; 188: 1445-51. 10.3402/pba.v2i0.17101.
  • Hamada Y, Fujii H, Kitazawa R, Yodoi J, Kitazawa S, Fukagawa M Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. 2009; 44: 936-41. 10.3402/pba.v2i0.17101.
  • Yamamoto M, Yamato E, Toyoda S, Tashiro F, Ikegami H, Yodoi J et al. Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus. 2008; 10: 43-9. 10.3402/pba.v2i0.17101.
  • DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. 1992; 15: 318-68. 10.3402/pba.v2i0.17101.